Weekly Briefing for November 8 to 14, 2026

From Physician in the Loop: Urology · 4:10

Show by Nomad Medical

The Food and Drug Administration (FDA) approved durvalumab with enfortumab vedotin-ejfv around radical cystectomy on Nov. 13 for cisplatin-ineligible muscle invasive bladder cancer, based on the VOLGA trial. The American Cancer Society (ACS) now recommends regular PSA-based screening, Virtuoso Surgical announced FDA De Novo authorization for its endoscopic robot for bladder tumor resection, and a two-model AI consensus abstracted prostatectomy registry data with fewer errors than humans.Read this week's roundup and its sources: https://physicianintheloop.org/specialties/urology/2026-11-08/Get this roundup by email, freeThe voices on this episode are generated by AI, and so is the script, from the week's specialty roundup at Physician in the Loop. Every fact in the roundup links to its source.

More episodes of Physician in the Loop: Urology

More episodes

PodSearch is a free, independent podcast search engine. Read about PodSearch, the privacy policy or contact us.